__________________________________________________________________________________ Torbay
Pharmaceuticals
for healthcare professionals in opening those glass ampoules. Furthermore, the US market would rather have a rubbersealed glass bottle with a crimp cap, so we’ ve invested into a high-speed vial filling line which enables us to increase our capacity to manufacture the quantities required in rubber bunged vials, rather than glass ampoules.”
Following these integral investments, the company is focused intently on defining its growth over the next 12 months, taking new technology and compliance with regulatory standards and delivering it outside of the UK, as well as continuing to grow its UK base. Not only is it concentrating on partnerships in the US but also exploring possible collaborations with companies in the EU, including France, Germany, Austria and across Scandinavia.
“ Our aim this year is to really expand our reach throughout those networks with the right partners,” Mark finalizes.“ Focusing further ahead, it’ s extremely important that we support and grow the number of opportunities for STEM-based roles in Torbay and South Devon and we’ re particularly keen on enhancing and developing opportunities for women in STEM. We already have local networks set up for women in STEM to increase the number of senior colleagues across engineering and manufacturing fields. Our aim is essentially to have a much larger Torbay Pharmaceuticals in the future, supplying products to an increased number of countries and providing multiple career opportunities for local people. Torbay Pharmaceuticals has a real chance to shape the industry – it’ s highly competitive but we strive to expand in the right way, honoring our NHS heritage. We want to forge valuable partnerships, grow our team, develop our people, and keep delivering even more products to patients.” ■
torbaypharma. com
manufacturing-today. com 203